Lymphoid Hematological Malignancies
5 clinical trials · Condition
◉ Watch Lymphoid Hematological Malignancies
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma (NCT04626908) | He Huang | 2020-11-20 |
| A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies (NCT04283006) | He Huang | 2018-05-23 |
| A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies (NCT02223598) | Cleave Biosciences, Inc. | 2014-08-25 |
| Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies (NCT01247688) | Baylor College of Medicine | 2010-11-01 |
Track Lymphoid Hematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.